JOHNSON & JOHNSON（JNJ）内部人交易：高管与董事近期交易
过去 18 个月，共有 13 位内部人为 JOHNSON & JOHNSON（JNJ）报告了 156 笔 Form 4 交易（最近一笔 2026-09-04）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-04 | Schmid Timothy | EVP, WW Chair, MedTech | 买入 | 11,070 | $1.5M |
| 2026-09-04 | Schmid Timothy | EVP, WW Chair, MedTech | 卖出 | 11,070 | $3.0M |
| 2026-09-04 | Schmid Timothy | EVP, WW Chair, MedTech | 买入 | 22,527 | $3.4M |
| 2026-09-04 | Schmid Timothy | EVP, WW Chair, MedTech | 卖出 | 22,527 | $6.2M |
| 2026-08-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 买入 | 15,000 | $1.7M |
| 2026-08-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 卖出 | 15,000 | $4.0M |
| 2026-08-14 | Duato Joaquin | CEO and Chairman of the Board | 买入 | 123,291 | $14.3M |
| 2026-08-14 | Duato Joaquin | CEO and Chairman of the Board | 卖出 | 20,976 | $5.5M |
| 2026-08-14 | Duato Joaquin | CEO and Chairman of the Board | 卖出 | 102,315 | $26.7M |
| 2026-08-07 | Duato Joaquin | CEO and Chairman of the Board | 卖出 | 41,957 | $10.8M |
| 2026-08-07 | Forminard Elizabeth | EVP, Chief Legal Officer | 买入 | 9,344 | $1.2M |
| 2026-08-07 | Duato Joaquin | CEO and Chairman of the Board | 卖出 | 6,523 | $1.7M |
| 2026-08-07 | Forminard Elizabeth | EVP, Chief Legal Officer | 卖出 | 9,344 | $2.4M |
| 2026-08-07 | Forminard Elizabeth | EVP, Chief Legal Officer | 卖出 | 6,574 | $1.7M |
| 2026-07-21 | Broadhurst Vanessa | EVP, Global Corp Affairs | 买入 | 11,129 | $1.4M |
| 2026-07-21 | Broadhurst Vanessa | EVP, Global Corp Affairs | 买入 | 11,925 | $1.6M |
| 2026-07-21 | Broadhurst Vanessa | EVP, Global Corp Affairs | 卖出 | 23,054 | $5.8M |
| 2026-06-12 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 卖出 | 10,000 | $2.4M |
| 2026-06-12 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 买入 | 10,000 | $1.2M |
| 2026-05-04 | REED JOHN C | EVP, Innovative Medicine, R&D | 买入 | 25,255 | $0 |
| 2026-05-04 | REED JOHN C | EVP, Innovative Medicine, R&D | 卖出 | 11,002 | $2.5M |
| 2026-03-03 | Decker Robert J | VP Corporate Controller | 买入 | 4,075 | $471,355 |
| 2026-03-03 | Decker Robert J | VP Corporate Controller | 卖出 | 4,075 | $1.0M |
| 2026-02-23 | Schmid Timothy | EVP, WW Chair, MedTech | 卖出 | 1,322 | $324,763 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 买入 | 1,302 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-04